CASP3 and ovarian carcinoma: Results presented in Fig. 6 suggest that enforced expression of Mcl-1 partially rescues ovarian carcinoma cell from calcium inhibitors + ABT-737-induced cytotoxicity as assessed by the decrease of the percentage of sub-G1 peak (45 vs 28 % for BAPTA-AM+ABT-737 condition and 61 vs 40 % W7+ABT-737 condition) (Fig. 6a), the increase of IGROV1-R10 cell viability (36 vs 66.5 % for BAPTA-AM+ABT-737 condition and 32 vs 53 % W7+ABT-737 condition) (Fig. 6b) and the reduction of Caspase 3 cleavage (Fig. 6c).